Global CAR T Cell Therapy Market to Reach US$ 8.5 Billion by 2028 : Coherent Market Insights

Global CAR T Cell Therapy Market, By Targeted Antigen(CD 19,CD 20, GD2, CD22, CD30,
CD33, HER1, HER2, Meso, EGFRvlll), Therapeutic Application(Acute Lymphocytic,
Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin Leukemia, Multiple Myeloma,
Pancreatic Cancer, Neuroblasta, Breast Cancer, Acute Myeloid Leukemia, Hepatocellular
Carcinoma, Colorectal Cancer), and Geography - Trends, Analysis and Forecast till 2028
[DATE]
[COMPANY NAME]
[Company address]
Global CAR T Cell Therapy Market to Reach US$ 8.5 Billion by
2028
Report Description
The Global Car T Cell Therapy Market is expected to be valued at US$ 8.5 Billion by 2028, as analyzed by Coherent
Market Insights. Increasing demand for genetically engineered treatment approach for high success rate in cancer
treatment along with growing cancer incidence rate are key factors driving demand for CAR T cell therapy products
worldwide.
Get FREE Sample PDF Of Car T Cell Therapy Market Report At :
https://www.coherentmarketinsights.com/insight/request-sample/102
Lately, CAR T cell therapy has emerged as the new pillar for cancer treatment, creating high market potential for
companies engaged in development and promotion of the product. Currently, Novartis International AG, Juno
Therapeutics and Kite Pharma Inc. are dominating the CAR T cell therapy market. Clinical research by these players
have revealed high rate of remission in patients with r/r B cell ALL and DLBCL. These companies are making major
investments in R&D to expedite the clinical process. Novartis invested around US$ 9 billion in R&D – significant share of
it is allocated towards oncology and development of CAR-T cell products in 2016. This novel cellular immunotherapy has
attracted significant investment in last two years.
CAR T cell therapy market is expected to be primarily driven by increasing demand for highly effective therapy mode of
treating cancer. Combating cancer has been a major concern for healthcare industry for years. CAR T cell works on gene
transfer technology that boosts the immune response of cancer affected individual by destroying affected tumor cells. It
has been analyzed to act as a lifesaving drug for over 30 million patients’ sufferings from lymphoma. Though the CAR T
cell therapy market outlook is highly optimistic, market players need to address the manufacturing and scalability options
to generate higher profits. Novartis and Kite have already started building a roadmap for it.
To know the latest trends and insights prevalent in this market, click the link below :
https://www.coherentmarketinsights.com/market-insight/car-t-cell-therapy-market-102
Key takeaways of the market are:




North America is expected to dominate the CAR T cell therapy market throughout the forecast period. The region
is expected to account for 58.3% of overall industry share by 2018. Leukemia, lymphoma, and myeloma
accounted for 9.4% of 1.6 million newly diagnosed cancer in 2015. Each year, around 55 thousand people die
due to leukemia, lymphoma and myeloma in U.S. Emergence of CAR T cell therapy is expected to address the
blood cancer concerns. Mortality rate is expected to be drastically lower by 2020 with the adoption of this novel
treatment approach.
Europe is expected to be the second largest market for CAR T cell therapy products manufacturers. Although,
the region is expected to create lucrative market opportunities, conducting country-specific clinical trials across
Europe is expected to be a cumbersome process for companies and is a key challenge for growth prospects in
the region.
CD 19 based therapy segment is expected to dominate the global CAR T cell therapy market revenue throughout
the forecast period. CD 19 segment is expected to touch a billion dollar mark by 2023. Much of the companies
are working on CD 19 to combat leukemia. Other antigens such as CD 20 and CD 22 are also expected to create
significant revenue opportunity for treatment of solid tumors.
At present, Novartis International AG and Kite Pharma Inc. are expected to launch their products in 2017. Juno
Therapeutics is expected to commercialize its product by 2018. Besides these players, Bellicum Pharmaceutical,
Celgene Corporation, and Cellectisare also engaged in R&D process and are focusing on curtailing time-tomarket for their product to capitalize the market potential in the following 10 years.
Browse Press Release : https://www.coherentmarketinsights.com/press-release/global-car-t-cell-therapymarket-to-reach-the-value-us-85-billion-by-2028-18
TABLE OF CONTENT
Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
 Market Definition and Scope
o Executive Summary
 Market Snippet By Targeted Antigen
 Market Snippet By Therapeutic Application
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
 Drivers
 Restraints
 Market Opportunities
 Regulatory Scenario
 Industry Trend
 Epidemiology/Prevalence/Incidence
 Merger and Acquisitions
 New Product Approvals/Launch
4. Global Car T Cell Therapy Market, By Targeted Antigen, 2017 - 2028 (US$ Million)
o Introduction
 Market Share Analysis, 2017 and 2028 (%)
 Y-O-Y Growth Analysis, 2017 - 2028
 Segment Trends
o CD 19
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o CD 20
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o GD2
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o
CD22


o
CD30


o


Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
HER2


o
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
HER1

o
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
CD33

o
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
Meso

Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o EGFRvlll
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Others
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
5. Global Car T Cell Therapy Market, By Therapeutic Application, 2017 - 2028 (USD Million)
o Introduction
 Market Share Analysis, 2017 and 2028 (%)
 Y-O-Y Growth Analysis, 2017 - 2028
 Segment Trends
o Acute Lymphocytic Leukemia
 Introduction
 Market Share Analysis, 2017 and 2028 (%)
 Y-O-Y Growth Analysis, 2017 - 2028
o Chronic Lymphocytic Leukemia
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Non Hodgkin Leukemia
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Multiple Myeloma
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
Pancreatic Cancer
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Neuroblasta
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Breast Cancer
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Acute Myeloid Leukemia
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Hepatocellular Carcinoma
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Colorectal Cancer
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Others
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
6. Global Car T Cell Therapy Market, By Regions, 2017 - 2028 (US$ Million)
o Introduction
 Market Share Analysis, By Region, 2017 and 2028 (%)
 Y-O-Y Growth Analysis, For Regions, 2017 - 2028
o North America
 Market Share Analysis, By Segments, 2017 and 2028 (%)
 Y-O-Y Growth Analysis, By Segments, 2017 - 2028
 Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
 Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
o Europe
 Market Share Analysis, By Segments, 2017 and 2028 (%)
 Y-O-Y Growth Analysis, By Segments, 2017 - 2028
 Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
 Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
o Asia Pacific
 Market Share Analysis, By Segments, 2017 and 2028 (%)
 Y-O-Y Growth Analysis, By Segments, 2017 - 2028
 Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
 Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
o Latin America
 Market Share Analysis, By Segments, 2017 and 2028 (%)
o

o
Y-O-Y Growth Analysis, By Segments, 2017 - 2028
 Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
 Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
Africa

Market Share Analysis, By Segments, 2017 and 2028 (%)
 Y-O-Y Growth Analysis, By Segments, 2017 - 2028
 Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
 Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
o Middle East
 Market Share Analysis, By Segments, 2017 and 2028 (%)
 Y-O-Y Growth Analysis, By Segments, 2017 - 2028
 Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
 Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
7. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profiles
 Novartis International AG
 Company Overview
 Product Portfolio
 Financial Performance
 Recent Developments/Updates
 Future Plans
 Kite Pharma Inc.
 Company Overview
 Product Portfolio
 Financial Performance
 Recent Developments/Updates
 Future Plans
 Juno Therapeutics
 Company Overview
 Product Portfolio
 Financial Performance
 Recent Developments/Updates
 Future Plans
 Bellicum Pharmaceuticals, Inc.
 Company Overview
 Product Portfolio
 Financial Performance
 Recent Developments/Updates
 Future Plans
 Celgene Corporation



Company Overview
 Product Portfolio
 Financial Performance
 Recent Developments/Updates
 Future Plans
Cellectis
 Company Overview
 Product Portfolio
 Financial Performance
 Recent Developments/Updates
 Future Plans
Analyst Views
8. Section
o References
o Research Methodology
o About us and Sales Contact
Browse Customization Report At : https://www.coherentmarketinsights.com/insight/requestcustomization/102
About Us
COMPANY OVERVIEW
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting
our plethora of clients achieve transformational growth by helping them make critical business decisions.
We are headquartered in India, having office at global financial capital in the U.S. Our client base includes
players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to
help businesses around the globe deliver practical and lasting results through various recommendations
about operational improvements, technologies, emerging market trends and new working methods. We
offer both customized and syndicated market research reports that help our clients create visionary growth
plans to provide traction to their business. We meticulously study emerging trends across various
industries at both the global and regional levels to identify new opportunities for our clientele. Our global
team of over 100 research analysts and freelance consultants provide market intelligence from the very
molecular country level and also provide a global perspective of the market. Our team is of the most vital
cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive
defusion training module.This allows for an objective and unbiased assessment of the market. We pride
ourselves in my constantly striving to update our extremely in-depth understanding of the market by
closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable
industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize
on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth
path in the future.
Contact Us
CONTACT US
Raj Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com/
Visit Blog : http://globalresearchtrends.blogspot.in/

The Global Car T Cell Therapy Market is expected to be valued at US$ 8.5 Billion by 2028, as analyzed by Coherent Market Insights. Increasing demand for genetically engineered treatment approach for high success rate in cancer treatment along with growing cancer incidence rate are key factors driving demand for CAR T cell therapy products worldwide.

Download Report

Global Electro-Diagnostic Equipment Market to 2017

US Green Building Material Market

Food Security Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2015 – 2023

Growth Of Water Treatment Systems Market 2016 - 2024

Food Security Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023

Food Security Technologies Market to be Propelled by Rapid Rise in Application in Agriculture Sector

Wind Energy Market

Global Produced Water Treatment Market to be Driven by Increasing Oil and Gas Exploration Activities

Global Process Manufacturing Consumption Industry Emerging Trends and Forecast 2021